Notably, these activated HSCs expressed high levels of lysophosphatidic acid receptor 1 (LPAR1), a G protein–coupled receptor that binds to lipid-signalling molecule LPA, and pharmacological inhibition significantly inhibited liver fibrosis. The gene discussed is LPAR1; the disease is Hepatic fibrosis.